Key Financial’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$677K Sell
4,148
-39
-0.9% -$6.5K 0.11% 152
2026
Q2
$783K Sell
4,187
-37
-0.9% -$6.96K 0.13% 137
2026
Q1
$818K Buy
4,224
+946
+29% +$182K 0.15% 130
2025
Q4
$603K Sell
3,278
-618
-16% -$108K 0.11% 151
2025
Q3
$657K Buy
3,896
+11
+0.3% +$1.66K 0.12% 146
2025
Q2
$543K Hold
3,885
– – 0.11% 161
2025
Q1
$571K Buy
3,885
+8
+0.2% +$1.16K 0.12% 147
2024
Q4
$508K Buy
3,877
+18
+0.5% +$2.52K 0.12% 151
2024
Q3
$601K Buy
3,859
+3
+0.1% +$484 0.13% 141
2024
Q2
$601K Sell
3,856
-317
-8% -$47.7K 0.14% 124
2024
Q1
$565K Sell
4,173
-829
-17% -$110K 0.14% 125
2023
Q4
$674K Buy
5,002
+100
+2% +$13K 0.18% 98
2023
Q3
$664K Buy
4,902
+4
+0.1% +$546 0.22% 87
2023
Q2
$701K Buy
4,898
+119
+2% +$17.5K 0.23% 84
2023
Q1
$663K Buy
4,779
+8
+0.2% +$1.08K 0.24% 81
2022
Q4
$523K Hold
4,771
– – 0.25% 79
2022
Q3
$523K Sell
4,771
-193
-4% -$24.5K 0.25% 79
2022
Q2
$655K Hold
4,964
– – 0.35% 50
2022
Q1
$659K Buy
4,964
+508
+11% +$60.9K 0.33% 56
2021
Q4
$519K Hold
4,456
– – 0.26% 72
2021
Q3
$535K Buy
4,456
+23
+0.5% +$2.68K 0.3% 64
2021
Q2
$507K Buy
4,433
+3,539
+396% +$388K 0.28% 71
2021
Q1
$89K Buy
894
+10
+1% +$1K 0.06% 204
2020
Q4
$88K Buy
+884
New +$93.6K 0.07% 191
2020
Q2
– Sell
-1,596
Closed -$142K – 134
2020
Q1
$142K Buy
+1,596
New +$150K 0.15% 118

Other funds holding AZN

Key Financial's AZN Position: Q3 2026 in Review

Key Financial reduced its AstraZeneca (AZN) stake by 0.93% in Q3 2026, selling an estimated $6.5K and leaving 4,148 shares worth $677K. The position accounts for 0.11% of the portfolio, ranked #152.

Key Financial first reported a position in AZN in Q1 2020 and has held it in 25 quarters since. The position peaked at $818K in Q1 2026. 1,222 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Key Financial held 4,148 shares of AstraZeneca worth $677K as of Q3 2026.
  • Key Financial sold 39 AstraZeneca shares in Q3 2026, an estimated $6.5K.
  • AstraZeneca made up 0.11% of Key Financial's portfolio in Q3 2026, its #152 holding.
  • Key Financial first reported a position in AstraZeneca in Q1 2020 and has held it in 25 quarters since.
  • Key Financial's AstraZeneca position peaked at $818K in Q1 2026.
  • 1,222 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Key Financial's 13F filing for Q3 2026, filed 2 Nov 2026.